CMRX Valuation
Chimerix Inc
$
0.000
- Overview
- Forecast
- Valuation
- Earnings
CMRX Relative Valuation
CMRX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CMRX is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
6.47
P/B
Median3y
1.39
Median5y
3.03
-9.40
FCF Yield
Median3y
-55.48
Median5y
-40.02
Competitors Valuation Multiple
The average P/S ratio for CMRX's competitors is 5.66, providing a benchmark for relative valuation. Chimerix Inc Corp (CMRX) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 1325.00%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
GOCO
Gohealth Inc
6.050
USD
+0.17%
MPX
Marine Products Corp
8.950
USD
-0.78%
NATH
Nathan's Famous Inc
95.680
USD
+1.28%
LFVN
LifeVantage Corp
13.710
USD
-1.93%
VMD
Viemed Healthcare Inc
6.120
USD
-2.70%
FSBW
FS Bancorp Inc
41.060
USD
-1.53%
XOMA
XOMA Royalty Corp
25.830
USD
+0.08%
PBPB
Potbelly Corp
12.560
USD
-0.63%
MVIS
MicroVision Inc
1.300
USD
-13.33%
HYAC
Haymaker Acquisition Corp 4
11.170
USD
+0.36%
FAQ
Is Chimerix Inc (CMRX) currently overvalued or undervalued?
Chimerix Inc (CMRX) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of -3.82. The fair price of Chimerix Inc (CMRX) is between to according to relative valuation methord.
What is Chimerix Inc (CMRX) fair value?
How does CMRX's valuation metrics compare to the industry average?
What is the current P/B ratio for Chimerix Inc (CMRX) as of Jul 26 2025?
What is the current FCF Yield for Chimerix Inc (CMRX) as of Jul 26 2025?
What is the current Forward P/E ratio for Chimerix Inc (CMRX) as of Jul 26 2025?